Vincent T. Mileto Named to NJBIZ 2025 People to Watch in Health Care
Orcosa
  • Technology
    Technology
    • RITe™ Platform

      Our breakthrough, proprietary technology platform engineered to enhance drug absorption

    • Capabilities

      End-to-end, in-house control of formulation, development, and manufacturing capabilities

  • Research
    Research
    • ORAVEXX™ Research + Development

      Our proprietary cannabinoid composition for the management of pain and inflammation

    • Research Partners

      Partnering with the world’s leading research institutions and doctors to support FDA-authorized investigator-initiated clinical trials

    • About Cannabidiol

      Learn more about cannabidiol from the medical community and regulators

  • Company
    Company
    • About Us

      We are modernizing the way medicines are taken

    • Our Team

      Experts in drug development and delivery, manufacturing, and commercialization

  • News
    News
    • In the News

      Recent media coverage regarding Orcosa

    • Press Releases and Blog Posts

      Company news and announcements

  • Careers
    Careers
Contact

Press Releases
and Blog Posts

Jan 30, 2024
Orcosa Announces Two New Appointments to Board of Directors 
Jun 14, 2023
Orcosa Announces Key Patent Granted by USPTO for ORAVEXX™ in Acute Pain
Sep 02, 2022
Orcosa Announces Positive Results from Phase 1/2 clinical trial utilizing ORAVEXX™ to be Presented at the European Society for Surgery of the Shoulder and Elbow, 30th SECEC-ESSSE Congress in Dublin
Aug 01, 2022
Orcosa Congratulates Michael J. Alaia, M.D., and Researchers at NYU Langone and Baptist Health on Publication of Landmark Results from Phase 1/2 Clinical Trial Utilizing ORAVEXX™ in The American Journal of Sports Medicine 
« Previous 1 2 3 4 5 Next »
  • Technology
  • Research
  • Company
  • Careers
Orcosa
© 2025 Orcosa. All rights reserved.
  • Privacy Policy
  • Accessibility Statement